In an ongoing collaboration between myNEO Therapeutics and Radboud University Medical Center, novel neoantigens arising from non-coding regions are being investigated that are shared among prostate cancer patients. An in-house developed machine learning...
myNEO Therapeutics will be present at the 18th CIMT Annual Meeting, Europe’s largest specialty meeting on cancer immunotherapy research, translation, and development. The plenary sessions range from pre-clinical research to clinical development on the topics of...
Fighting Cancer with Personalized Vaccines: ONCODNA and myNEO Therapeutics collaboration OncoDNA, a company specializing in precision medicine, and myNEO Therapeutics, an AI-driven company revolutionizing neoantigen discovery within immuno-oncology, are thrilled to...
This week the myNEO team had multiple reasons to celebrate! Bruno his promotion to CTO 1 year working anniversary of Lore and Lien End of the internship of Claudia 500+ followers on LinkedIn We had a great night over drinks and some...
Yesterday myNEO organised its first teambuilding activity after the lockdown. We all worked remotely during the lockdown so it was nice to all be together again as a team. We had some drinks, ate a tasty diner and played some board games to finish off the...
